Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols-Reference-Cited by-同舟云学术

Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols

Published:2015-07-01 Issue:3 Volume:102 Page:318-326
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Tomizawa Daisuke,Watanabe Tomoyuki,Hanada Ryoji,Horibe Keizo,Horikoshi Yasuo,Iwamoto Shotaro,Kinoshita Akitoshi,Moritake Hiroshi,Nakayama Hideki,Shimada Akira,Taga Takashi,Takahashi Hiroyuki,Tawa Akio,Terui Kiminori,Hori Hiroki,Kawano Yoshifumi,Kikuta Atsushi,Manabe Atsushi,Adachi Souichi

Funder

Ministry of Health, Labour and Welfare

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-015-1825-x.pdf

Reference32 articles.

1. Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, et al. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. J Clin Oncol. 2009;27:4007–13.

2. Rubnitz JE, Inaba H, Dahl G, Ribeiro RC, Bowman WP, Taub J, et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010;11:543–52.

3. Creutzig U, Zimmermann M, Bourquin J-P, Dworzak MN, Fleischhack G, Graf N, et al. Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004. Blood. 2013;122:37–43.